MEDULLARY CATECHOLAMINERGIC NEURONS IN THE NORMAL HUMAN BRAIN AND IN PARKINSONS-DISEASE

被引:75
|
作者
SAPER, CB
SORRENTINO, DM
GERMAN, DC
DELACALLE, S
机构
[1] UNIV CHICAGO, DEPT NEUROL, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, COMM NEUROBIOL, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, BRAIN RES INST, CHICAGO, IL 60637 USA
[4] UNIV TEXAS, SW MED CTR, DEPT PSYCHIAT, DALLAS, TX 75230 USA
[5] UNIV TEXAS, SW MED CTR, DEPT PHYSIOL, DALLAS, TX 75230 USA
[6] UNIV NAVARRA, DEPT ANAT, PAMPLONA, SPAIN
关键词
D O I
10.1002/ana.410290602
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is thought to cause degeneration of melanin-pigmented catecholaminergic neurons throughout the brainstem, but little quantitative information is available on the fate of catecholaminergic neurons associated with the dorsal vagal complex or medullary reticular formation. We therefore examined these neurons in the normal human medulla and in the brains of patients with Parkinson's disease, using both a melanin stain and immunohistochemical methods with an antiserum against tyrosine hydroxylase. The greatest numbers of catecholaminergic neurons in the ventrolateral reticular formation (A1/C1 group) were located in the far rostral medulla, whereas the largest populations of catecholaminergic cells in the dorsal vagal complex (A2/C2 group) were found at the level of the area postrema. No loss of cells was observed in the A1/C1 group in the parkinsonian brains. In contrast, the A2/C2 group showed moderate loss of neurons, most marked at the level of the area postrema. This difference was entirely due to the loss of neurons in the medial component of the A2 group, a population that normally is only lightly pigmented, while the heavily pigmented neurons in the ventral and intermediate components of the A2 complex were unaffected. Parkinson's disease causes degeneration only of selected populations of medullary catecholaminergic neurons, without apparent relationship to the extent of melanin pigmentation.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 50 条
  • [32] TRANSFERRIN AND IRON IN NORMAL, ALZHEIMERS-DISEASE, AND PARKINSONS-DISEASE BRAIN-REGIONS
    LOEFFLER, DA
    CONNOR, JR
    JUNEAU, PL
    SNYDER, BS
    KANALEY, L
    DEMAGGIO, AJ
    NGUYEN, H
    BRICKMAN, CM
    LEWITT, PA
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 (02) : 710 - 716
  • [33] TRANSPLANTATION OF ADRENAL-MEDULLARY TISSUE TO BRAIN IN PARKINSONS-DISEASE - IMPLICATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    BURNS, RS
    ALZHEIMERS AND PARKINSONS DISEASES /: RECENT ADVANCES IN RESEARCH AND CLINICAL MANAGEMENT, 1989, : 339 - 346
  • [34] ADRENAL-MEDULLARY TRANSPLANTATION INTO THE BRAIN FOR TREATMENT OF PARKINSONS-DISEASE - CLINICAL OUTCOME AND NEUROCHEMICAL STUDIES
    AHLSKOG, JE
    KELLY, PJ
    VANHEERDEN, JA
    STODDARD, SL
    TYCE, GM
    WINDEBANK, AJ
    BAILEY, PA
    BELL, GN
    BLEXRUD, MD
    CARMICHAEL, SW
    MAYO CLINIC PROCEEDINGS, 1990, 65 (03) : 305 - 328
  • [35] ADRENAL-MEDULLARY TISSUE-TRANSPLANTATION IN PARKINSONS-DISEASE
    IACONO, RP
    SANDYK, R
    JOURNAL OF NEUROSURGERY, 1988, 68 (01) : 158 - 159
  • [36] STEREOTAXIC TRANSPLANTATION OF ADRENAL-MEDULLARY TISSUE IN PARKINSONS-DISEASE
    CHUNG, SS
    KIM, SH
    YOON, DH
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1990, 54-5 : 272 - 276
  • [37] ADRENAL-MEDULLARY TRANSPLANTS AS A TREATMENT FOR ADVANCED PARKINSONS-DISEASE
    LIEBERMAN, A
    RANSOHOFF, J
    BERCZELLER, P
    BROUS, P
    ENG, K
    GOLDSTEIN, M
    KAUFMAN, B
    KOSLOW, M
    CHIN, L
    ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 : 189 - 196
  • [38] ADRENAL-MEDULLARY TRANSPLANTS AS A TREATMENT FOR ADVANCED PARKINSONS-DISEASE
    LIEBERMAN, A
    RANSOHOFF, J
    BERCZELLER, P
    GOLDSTEIN, M
    PROGRESS IN BRAIN RESEARCH, 1990, 82 : 665 - 669
  • [39] UNFAVORABLE OUTCOME OF ADRENAL-MEDULLARY TRANSPLANT FOR PARKINSONS-DISEASE
    FORNO, LS
    LANGSTON, JW
    ACTA NEUROPATHOLOGICA, 1991, 81 (06) : 691 - 694
  • [40] SULFONYLUREA BINDING-SITES IN NORMAL HUMAN BRAIN AND IN PARKINSONS-DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND HUNTINGTONS-DISEASE
    HOLEMANS, S
    JAVOYAGID, F
    AGID, Y
    DEPAERMENTIER, F
    LATERRE, EC
    MALOTEAUX, JM
    BRAIN RESEARCH, 1994, 642 (1-2) : 327 - 333